Aussie Pharmacists Warn Driving Down Prices Will Drive Pharmas Out
This article was originally published in PharmAsia News
Australian pharmacists complain the government's emphasis on driving down the price of drugs could have the effect of driving pharmaceutical companies out of the country. The head of the Pharmacy Guild of Australia acknowledged lower drug prices would be welcome news to Australians, but he warned the country to take a lesson from New Zealand. Guild president Kos Sclavos said New Zealand's low prices already have crippled its pharmaceutical industry because the price levels were not sustainable. (Click here for more)
You may also be interested in...
Gilead says remdesivir improved mortality and clinical recovery in COVID-19 patients, but the findings come from a retrospective analysis, not a traditional clinical trial.
Agency resuming domestic inspections with the help of a pandemic rating system to identify localities where inspections will be safest for investigators and plant workers. Another safety factor: all inspections will be pre-announced.
Poseida, Nkarta and Inventiva raised $224m, $252m and $107.7m, respectively. Also, Forbion raised €185m ($208m) of a new €250m fund and Blackstone closed the last $1.2bn of its $4.6bn fund for public and private company deals, and Ascendis led recent follow-ons with a $569.2m offering.